Effect of a novel immunosuppressive agent, deoxyspergualin, on rejection in kidney transplant recipients.
Takahashi
K
K
Department of Surgery and Urology, Tokyo Women's Medical College, Japan.
Ota
K
K
Tanabe
K
K
Oba
S
S
Teraoka
S
S
Toma
H
H
Agishi
T
T
Kawaguchi
H
H
Ito
K
K
D001379:Azathioprine / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection; D006146:Guanidines / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D012263:Ribonucleosides / Q000627:therapeutic use
D003524:Cyclosporins; D006146:Guanidines; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D001379:Azathioprine; C037258:gusperimus; D008775:Methylprednisolone